LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $473,736 | +69567.1% | 7,906 | -17.5% | 0.00% | -60.0% |
| Q4 2022 | $680 | -99.9% | 9,587 | -21.8% | 0.01% | -44.4% |
| Q3 2022 | $1,065,000 | -20.3% | 12,267 | -14.4% | 0.01% | -18.2% |
| Q2 2022 | $1,336,000 | -8.8% | 14,327 | +0.5% | 0.01% | 0.0% |
| Q1 2022 | $1,465,000 | -10.7% | 14,257 | +1.6% | 0.01% | -8.3% |
| Q4 2021 | $1,641,000 | -20.3% | 14,032 | -7.2% | 0.01% | 0.0% |
| Q3 2021 | $2,060,000 | -50.6% | 15,117 | -62.9% | 0.01% | -52.0% |
| Q2 2021 | $4,170,000 | -32.4% | 40,750 | -3.4% | 0.02% | -32.4% |
| Q1 2021 | $6,169,000 | -21.7% | 42,192 | -23.6% | 0.04% | -26.0% |
| Q4 2020 | $7,877,000 | +76.1% | 55,233 | +5.0% | 0.05% | +56.2% |
| Q3 2020 | $4,474,000 | +6.4% | 52,619 | +54.4% | 0.03% | 0.0% |
| Q2 2020 | $4,203,000 | +18.0% | 34,078 | -6.6% | 0.03% | -3.0% |
| Q1 2020 | $3,562,000 | +23.1% | 36,482 | +13.3% | 0.03% | +50.0% |
| Q4 2019 | $2,893,000 | -21.0% | 32,213 | -3.6% | 0.02% | -24.1% |
| Q3 2019 | $3,663,000 | +27.8% | 33,421 | +31.0% | 0.03% | +26.1% |
| Q2 2019 | $2,867,000 | -18.0% | 25,507 | -6.5% | 0.02% | -17.9% |
| Q1 2019 | $3,498,000 | +2.4% | 27,293 | -7.4% | 0.03% | -3.4% |
| Q4 2018 | $3,416,000 | -38.3% | 29,463 | -2.7% | 0.03% | -35.6% |
| Q3 2018 | $5,535,000 | -22.9% | 30,284 | -6.4% | 0.04% | -10.0% |
| Q2 2018 | $7,175,000 | +28.4% | 32,356 | -2.4% | 0.05% | +25.0% |
| Q1 2018 | $5,589,000 | +16.1% | 33,151 | +12.8% | 0.04% | +25.0% |
| Q4 2017 | $4,815,000 | +27.0% | 29,400 | +10.8% | 0.03% | +18.5% |
| Q3 2017 | $3,791,000 | +49.9% | 26,531 | +29.8% | 0.03% | +42.1% |
| Q2 2017 | $2,529,000 | +6.1% | 20,438 | -4.7% | 0.02% | +5.6% |
| Q1 2017 | $2,384,000 | +9.4% | 21,445 | +3.9% | 0.02% | +5.9% |
| Q4 2016 | $2,179,000 | +13.3% | 20,631 | +5.7% | 0.02% | +6.2% |
| Q3 2016 | $1,924,000 | -13.5% | 19,525 | +1.5% | 0.02% | -15.8% |
| Q2 2016 | $2,224,000 | -3.1% | 19,237 | +4.5% | 0.02% | -5.0% |
| Q1 2016 | $2,294,000 | +27.4% | 18,414 | +0.2% | 0.02% | +11.1% |
| Q4 2015 | $1,800,000 | +15.2% | 18,385 | +0.8% | 0.02% | +20.0% |
| Q3 2015 | $1,562,000 | -57.2% | 18,239 | -49.6% | 0.02% | -6.2% |
| Q2 2015 | $3,648,000 | +167.3% | 36,162 | +104.3% | 0.02% | +33.3% |
| Q1 2015 | $1,365,000 | -27.8% | 17,700 | -50.2% | 0.01% | +50.0% |
| Q4 2014 | $1,890,000 | +115.8% | 35,526 | +90.5% | 0.01% | 0.0% |
| Q3 2014 | $876,000 | -30.5% | 18,649 | -7.9% | 0.01% | -27.3% |
| Q2 2014 | $1,261,000 | -8.0% | 20,252 | -0.6% | 0.01% | +10.0% |
| Q1 2014 | $1,370,000 | +24.2% | 20,366 | -2.9% | 0.01% | +11.1% |
| Q4 2013 | $1,103,000 | – | 20,978 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |